Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Montelukast Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.5% during the forecast period.
This report presents the market size and development trends by detailing the Montelukast Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Montelukast Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Montelukast Drug industry and will help you to build a panoramic view of the industrial development.
Montelukast Drug Market, By Type:
Tablet
Chewable tablet
Oral Granules
Montelukast Drug Market, By Application:
Hospital
Drug store
Others
Some of the leading players are as follows:
Ajanta Pharma
Shanghai Anbison Lab
Merck & Co
Unichem Laboratories
Cipla
Amneal Pharmaceuticals
Dr. Reddys Laboratories
Hikma Group
Torrent Pharmaceuticals
Perrigo
Glenmark Pharmaceuticals
Dr Reddys Laboratories
Sandoz
CSPC Ouyi Pharmaceutical
Aurobindo Pharma
Teva.
Apotex
Lannett Company
Accord Healthcare
MACLEODS
Hetero
Mylan
Unimark
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Montelukast Drug Market: Technology Type Analysis
-
4.1 Montelukast Drug Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Montelukast Drug Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Tablet
4.3.2 Chewable tablet
4.3.3 Oral Granules
5 Montelukast Drug Market: Product Analysis
-
5.1 Montelukast Drug Product Market Share Analysis, 2018 & 2026
-
5.2 Montelukast Drug Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Montelukast Drug Market: Application Analysis
-
6.1 Montelukast Drug Application Market Share Analysis, 2018 & 2026
-
6.2 Montelukast Drug Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospital
6.3.2 Drug store
6.3.3 Others
7 Montelukast Drug Market: Regional Analysis
-
7.1 Montelukast Drug Regional Market Share Analysis, 2018 & 2026
-
7.2 Montelukast Drug Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Ajanta Pharma
9.1.1 Ajanta Pharma Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Shanghai Anbison Lab
9.2.1 Shanghai Anbison Lab Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Merck & Co
9.3.1 Merck & Co Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Unichem Laboratories
9.4.1 Unichem Laboratories Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Cipla
9.5.1 Cipla Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Amneal Pharmaceuticals
9.6.1 Amneal Pharmaceuticals Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Dr. Reddys Laboratories
9.7.1 Dr. Reddys Laboratories Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Hikma Group
9.8.1 Hikma Group Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Torrent Pharmaceuticals
9.9.1 Torrent Pharmaceuticals Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Perrigo
9.10.1 Perrigo Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Glenmark Pharmaceuticals
9.11.1 Glenmark Pharmaceuticals Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Dr Reddys Laboratories
9.12.1 Dr Reddys Laboratories Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Sandoz
9.13.1 Sandoz Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 CSPC Ouyi Pharmaceutical
9.14.1 CSPC Ouyi Pharmaceutical Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Aurobindo Pharma
9.15.1 Aurobindo Pharma Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Teva.
9.16.1 Teva. Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 Apotex
9.17.1 Apotex Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
9.18 Lannett Company
9.18.1 Lannett Company Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.18.5 SWOT analysis
9.19 Accord Healthcare
9.19.1 Accord Healthcare Company overview
9.19.2 Financial performance
9.19.3 Product benchmarking
9.19.4 Strategic initiatives
9.19.5 SWOT analysis
9.20 MACLEODS
9.20.1 MACLEODS Company overview
9.20.2 Financial performance
9.20.3 Product benchmarking
9.20.4 Strategic initiatives
9.20.5 SWOT analysis
9.21 Hetero
9.21.1 Hetero Company overview
9.21.2 Financial performance
9.21.3 Product benchmarking
9.21.4 Strategic initiatives
9.21.5 SWOT analysis
9.22 Mylan
9.22.1 Mylan Company overview
9.22.2 Financial performance
9.22.3 Product benchmarking
9.22.4 Strategic initiatives
9.22.5 SWOT analysis
9.23 Unimark
9.23.1 Unimark Company overview
9.23.2 Financial performance
9.23.3 Product benchmarking
9.23.4 Strategic initiatives
9.23.5 SWOT analysis
The List of Tables and Figures (Totals 87 Figures and 121 Tables)
Figure Tablet Montelukast Drug market, 2015 - 2026 (USD Million)
Figure Chewable tablet Montelukast Drug market, 2015 - 2026 (USD Million)
Figure Oral Granules Montelukast Drug market, 2015 - 2026 (USD Million)
Figure Hospital market, 2015 - 2026 (USD Million)
Figure Drug store market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Montelukast Drug market, by country, 2015 - 2026 (USD Million)
-
Table North America Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table North America Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table North America Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table Canada Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table Canada Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Europe Montelukast Drug market, by country, 2015 - 2026 (USD Million)
-
Table Europe Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table Europe Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table Europe Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table Germany Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table Germany Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table France Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table France Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table Italy Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table Italy Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table Spain Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table Spain Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Montelukast Drug market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table China Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table China Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table Japan Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table Japan Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table India Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table India Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Montelukast Drug market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table MEA Montelukast Drug market, by country, 2015 - 2026 (USD Million)
-
Table MEA Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table MEA Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table MEA Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Montelukast Drug market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Montelukast Drug market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Montelukast Drug market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Ajanta Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shanghai Anbison Lab Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Unichem Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cipla Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Amneal Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Dr. Reddys Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hikma Group Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Torrent Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Perrigo Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Glenmark Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Dr Reddys Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sandoz Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CSPC Ouyi Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aurobindo Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teva. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Apotex Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lannett Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Accord Healthcare Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table MACLEODS Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hetero Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mylan Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Unimark Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
